# Sodium Nitrate for Muscular Dystrophy

> **NCT02434627** · PHASE1 · COMPLETED · sponsor: **Cedars-Sinai Medical Center** · enrollment: 5 (actual)

## Conditions studied

- Becker Muscular Dystrophy

## Interventions

- **DRUG:** Sodium Nitrate

## Key facts

- **NCT ID:** NCT02434627
- **Lead sponsor:** Cedars-Sinai Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-06
- **Primary completion:** 2018-04
- **Final completion:** 2018-04
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2020-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02434627

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02434627, "Sodium Nitrate for Muscular Dystrophy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02434627. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*